Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Ezetimibe

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT01948648Not ApplicableUnknownPrimary

Effects of Fish Oil and Colesevelam (STAIR7007)

NCT01584206Not ApplicableCompletedPrimary

Sitosterolemia Metabolism

NCT00531128Not ApplicableCompletedPrimary

The Effect of Dietary Sitosterol on Blood Sugar and Cholesterol

NCT00004481Completed

Genetic Study of Sitosterolemia

Showing all 4 trials

Research Network

Common Treatments

  • Ezetimibe1
  • Genetic Testing1
  • Combination Of Fish Oil And Colesevelam1
  • Fish Oil1
  • Highlow Sitosterol1

Active Sponsors

  • University of Manitoba2
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
  • National Center for Research Resources (NCRR)1
  • Medical University of South Carolina1

Top Investigators

Related Conditions

  • Lipid Metabolism Inborn Errors1

Activity Timeline